INTRACHOL

Serial Number 88143163
606

Registration Progress

Application Filed
Oct 4, 2018
Under Examination
May 7, 2019
Approved for Publication
Mar 12, 2019
Published for Opposition
Mar 12, 2019
Registered

Basic Information

Serial Number
88143163
Filing Date
October 4, 2018
Published for Opposition
March 12, 2019
Abandonment Date
June 13, 2022
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 13, 2022
Classes
005

Rights Holder

PROTARA THERAPEUTICS, INC.

03
Address
1 LITTLE WEST 12TH STREET
NEW YORK, NY 10014

Ownership History

ArTara Therapeutics, Inc.

Original Applicant
03
New York, NY

ArTara Therapeutics, Inc.

Owner at Publication
03
New York, NY

PROTARA THERAPEUTICS, INC.

New Owner After Publication #1
03
NEW YORK, NY

Legal Representation

Attorney
Richard J. Groos

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

46 events
Date Code Type Description
Jun 13, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Jun 13, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 30, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 29, 2021 EX5G S SOU EXTENSION 5 GRANTED
Oct 26, 2021 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 26, 2021 EXT5 S SOU EXTENSION 5 FILED
May 1, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 29, 2021 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 29, 2021 EXT4 S SOU EXTENSION 4 FILED
Apr 29, 2021 EX4G S SOU EXTENSION 4 GRANTED
Mar 2, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 2, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 2, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 8, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 7, 2020 EX3G S SOU EXTENSION 3 GRANTED
Nov 19, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 11, 2020 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 5, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 5, 2020 EXT3 S SOU EXTENSION 3 FILED
May 1, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 29, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 29, 2020 EXT2 S SOU EXTENSION 2 FILED
Apr 29, 2020 EX2G S SOU EXTENSION 2 GRANTED
Apr 28, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 28, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 28, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 28, 2020 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 28, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 28, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 9, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 7, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 7, 2019 EXT1 S SOU EXTENSION 1 FILED
Nov 7, 2019 EX1G S SOU EXTENSION 1 GRANTED
May 7, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 12, 2019 PUBO A PUBLISHED FOR OPPOSITION
Mar 12, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 20, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 1, 2019 ALIE A ASSIGNED TO LIE
Jan 17, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN
Jan 17, 2019 GNEA F EXAMINERS AMENDMENT E-MAILED
Jan 17, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 17, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED
Jan 17, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 16, 2019 DOCK D ASSIGNED TO EXAMINER
Oct 13, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 8, 2018 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, choline chloride intravenous preparation for injection, co-administered with parenteral support, for the treatment and prevention of Intestinal Failure Associated Liver Disease (IFALD) also known as total parenteral nutrition (TPN) associated liver disease
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005